Valuence Merger Corp. IVMCAF
時価総額
PER
ヘルスケアとサステナビリティ領域で企業買収を行うSPACの新興企業。成長企業への資本提供とPMI支援を展開。買収対象は企業価値2億〜10億ドル。2025年2月28日に買収未達で3月11日にナスダック上場廃止。アジア（中国・香港・マカオ除く）を対象。
| 2022年 12月31日 | 2023年 12月31日 | 2024年 12月31日 | |
| Net income | 630,602 | 5 | 2 |
| Interest earned on investments and cash held in Trust Account | - | - | 2 |
| Prepaid expenses | - | -444,374 | -29,596 |
| Accrued expenses and accounts payable | - | 239,176 | -1,461,825 |
| Net cash used in operating activities | -1,149,743 | -708,533 | -949,691 |
| Investment of cash into Trust Account | - | 1 | 784,088 |
| Cash withdrawn from Trust Account in connection with redemption | - | - | 50 |
| Net cash provided by investing activities | -226,702,619 | 167 | 49 |
| Advances from related party | - | - | 810,000 |
| Proceeds from convertible promissory notes - sponsor | - | 2 | 300,000 |
| Proceeds from convertible promissory note - related party | - | 613,207 | - |
| Payment of offering costs | 607,761 | 70,000 | - |
| Redemption of ordinary shares | - | 168 | 50 |
| Net cash used in financing activities | 228 | -165,637,058 | -48,790,380 |
| Net Change in Cash | 140,503 | 365,615 | -623,779 |